This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Fredax Ab, Janssen Biotech, Inc.. Active years: 2016-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2025
Title: Sven-Niklas Anders Axelsson: Innovator in Therapeutic Agents
Introduction
Sven-Niklas Anders Axelsson is a notable inventor based in Bjarred, Sweden. He has made significant contributions to the field of therapeutic agents, particularly in the treatment of prostate cancer. With a total of two patents to his name, Axelsson's work is paving the way for advancements in medical treatments.
Latest Patents
Axelsson's latest patents focus on therapeutic agents that target kallikrein proteins, such as PSA and hK2. These agents are designed for use in the treatment of prostate cancer. The patents detail methods for administering a therapeutically effective amount of these agents to patients, showcasing innovative approaches to combat this prevalent disease.
Career Highlights
Throughout his career, Axelsson has worked with reputable companies, including Fredax AB and Janssen Biotech, Inc. His experience in these organizations has contributed to his expertise in developing therapeutic solutions.
Collaborations
Axelsson has collaborated with talented individuals in his field, including Sven-Erik Strand and Amanda Thuy Tran. These partnerships have likely enhanced his research and development efforts.
Conclusion
Sven-Niklas Anders Axelsson is a distinguished inventor whose work in therapeutic agents is making a significant impact in the treatment of prostate cancer. His innovative patents and collaborations reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile